UiPath’s Growth Engine Is Sputtering—And the CEO’s Silence Says It All

Posted on by Elim
PATH earnings-call technical analysis chart — Stage 2 (Advancing), Double Bottom, Breakout, Golden Cross, 52wk High, 52wk Low, last price $17.99, as of September 04, 2026 at 08:51

Continue Reading

This article is for pass holders.

Already a pass holder? Sign in · Continue with Google

In Short

UiPath beat Q2 estimates but revenue fell sequentially to $410M from $418M, and ARR growth slowed to its weakest pace in years. Management hid net revenue retention and AI revenue figures. The AI story isn't moving the needle—yet. Is this a beat or a carefully dressed miss? Read the full breakdown.

Inside the Full Analysis

  • 🔒The Real Story: A Beat That Feels Like a Miss
  • 🔒The Missing Numbers: What Management Didn’t Say
  • 🔒Script vs. Reality: Confidence That Cracked
  • 🔒Evasion Tactics & The Hot Seat: Three Questions They Dodged
  • 🔒Excuses vs. Execution: The FX Scapegoat
  • 🔒The CAN SLIM Check
  • 🔒Conclusion

Discover more from CANSLIM Research

Subscribe to get the latest posts sent to your email.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.

Related Posts

Discover more from CANSLIM Research

Subscribe now to keep reading and get access to the full archive.

Continue reading